Aprea Therapeutics, Inc.
APRE
$1.84
-$0.0799-4.16%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.08M | -12.96M | -13.51M | -12.93M | -12.72M |
| Total Depreciation and Amortization | 21.50K | 22.30K | 21.90K | 17.90K | 12.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 575.80K | 435.10K | 509.80K | 404.10K | 483.10K |
| Change in Net Operating Assets | 231.80K | -1.06M | -809.90K | -1.05M | -913.30K |
| Cash from Operations | -13.25M | -13.56M | -13.79M | -13.56M | -13.13M |
| Capital Expenditure | -7.50K | -15.50K | -22.70K | -108.60K | -101.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -7.50K | -15.50K | -22.70K | -108.60K | -101.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 200.00K | 16.14M | 16.00M | 16.00M | 16.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -32.10K | -1.32M | -1.31M | -1.31M | -1.29M |
| Cash from Financing | 167.90K | 14.82M | 14.69M | 14.69M | 14.71M |
| Foreign Exchange rate Adjustments | -3.30K | -7.10K | 17.90K | -10.20K | -58.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.09M | 1.24M | 897.20K | 1.01M | 1.42M |